Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Why Iovance Biotherapeutics Stock Was on Fire Today

Key PointsHappily for investors, it flagged the biotech's shares as a buy.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

More from Friday 25 September →